Legal regulation of personalized medicine in the agricultural sector: the experience of Russia

Institute of Legislation and Comparative Law under the Government of the Russian Federation, 34, Cheremushkinskaya str., 117218, Moscow, Russia

^* Corresponding author: sevalnev77@gmail.com

Abstract

This study’s topic’s relevance is due to the rapid development of genetic research, when diagnostics, prevention, and treatment are carried out through the study of nucleic acids and their expression products − RNA and proteins. Predictive (personalized) medicine (PMM) has become a preventive trend in molecular medicine, understood in different ways. However, its generally accepted features recognize the individual nature of treatment (each person’s genome is individual). The prophylactic focus of medicine (analysis of the genome is possible at any stage of ontogenesis, long before the disease’s onset) is very important. In carrying out genetic certification, the need to find a legal solution to existing or projected problems is actualized. Legal science is designed to address the issues of protecting human rights in the process of genetic certification, countering discrimination, and other possible violations of constitutional values. The issues raised in the article acquire particular importance in the context of the covid-19 pandemic. Mobility and speed of decision-making require an appropriate legal approach to telemedicine, which will provide the population with high-quality and professional medical care. Besides, it seems reasonable to observe the balance of human rights and freedoms when using the institution of genetic certification and telemedicine